The imprinted oncofetal lncRNA H19, which normally controls mRNA expression by acting as a miRNA sponge, has been reported to be an oncogene in a variety of cancers, including LUAD, and a powerful therapeutic target for counteracting resistance to chemotherapy and radiotherapy 40, 41. This evidence concerns the gene H19 and cancer.